Publications by authors named "Muhammad Waqas Shahzad"

Article Synopsis
  • Chronic Kidney Disease (CKD) is a major global health issue that often coexists with cardiovascular disease (CVD), significantly increasing the risk of heart-related problems and mortality for CKD patients.
  • Effective risk assessment through biomarkers, advanced imaging, and personalized treatment plans is essential for managing cardiovascular risks in CKD patients, alongside lifestyle changes and early interventions.
  • Ongoing research into new therapies and the importance of interdisciplinary care aims to improve patient outcomes by addressing the complex relationship between CKD and cardiovascular health.
View Article and Find Full Text PDF

Obesity, a widespread health concern characterized by the excessive accumulation of body fat, is a complex condition influenced by genetics, environment, and social determinants. Recent research has increasingly focused on the role of gut microbiota in obesity, highlighting its pivotal involvement in various metabolic processes. The gut microbiota, a diverse community of microorganisms residing in the gastrointestinal tract, interacts with the host in a myriad of ways, impacting energy metabolism, appetite regulation, inflammation, and the gut-brain axis.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Muhammad Waqas Shahzad"

  • Muhammad Waqas Shahzad's recent research focuses on critical health issues, including the interplay between chronic kidney disease (CKD) and cardiovascular health, as well as the influence of gut microbiota on obesity management.
  • His article on CKD highlights the urgent link between kidney damage and cardiovascular disease, emphasizing its significance as a growing global health challenge.
  • In another study, he explores how gut microbiota contributes to obesity, underscoring its role in metabolic processes and suggesting potential avenues for intervention beyond traditional lifestyle changes.